Author: Vanessa

Delta-9 hemp beverages have momentum; the question is who can execute. Canopy USA’s partnership with JP Brand Advisors signals a bid to professionalize the category fast and move Wana from promising SKU to reliable national line. Canopy’s new partnership with JP Brand Advisors (JPBA), a seasoned sales and strategy firm from the wine and spirits world, could mark a pivotal moment for the hemp beverage category and for how the U.S. consumes cannabis. From Spirits to Cannabis Brooks Jorgensen, President of Canopy USA, has spent more than two decades navigating the traditional three-tier beverage distribution system. Before joining Canopy in…

Read More

Few figures in cannabis embody both the visionary drive and technical rigor of Mike Straumietis, the founder of Advanced Nutrients. Known throughout the cultivation world as “BigMike,” he has spent more than two decades chasing a singular goal: unlocking the plant’s full genetic potential. From early tissue-sample experiments in the 1990s to today’s eighth-generation nutrient formulations, Straumietis has built his company on an unyielding belief that cannabis can and should be treated like any high-value agricultural crop. When Cannabis & Tech Today caught up with him, Straumietis was in the thick of preparing for MJBizCon, where Advanced Nutrients remains a…

Read More

The legalisation of recreational cannabis in US states has not led to a statistically significant increase in hospital admissions for cannabis use disorder amongst teenagers, according to a comprehensive study published in the International Journal of Drug Policy.Researchers analysed 2,861,324 inpatient discharge records for adolescents aged 10-17 across 13 US states between 2008 and 2020, examining whether state cannabis legalisation affected the prevalence of cannabis use disorder (CUD) diagnoses in hospital settings.Cannabis use disorder is diagnosed in patients who meet at least two of the 11 criteria required by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition. The…

Read More

The new year brings with it groundbreaking news in cannabis policy, business, and culture. As we wade into 2026, Cannabis & Tech Today is catching you up on the latest breaking news and industry developments. Here’s what you may have missed over the last week: Resolutions to Reduce Cannabis Use in 2026 A survey commissioned by Northerner.com found that 8% of Americans plan to quit or reduce cannabis use as a 2026 New Year’s resolution. Conducted by Censuswide with 1,000 U.S. adults, the results highlight generational and gender differences: 13% of 21-24 year olds and 12% of 25-34 year olds…

Read More

Cannabis and wellness products are everywhere, but consistency and effectiveness are often a guessing game. Leading the team is Rick Cytrynbaum, a veteran of the fashion world turned cannabis innovator. According to Cytrynbaum, Capsoil is tearing up the rulebook on how cannabinoids, nutraceuticals, and other bioactive compounds reach the bloodstream. This offers a faster, cleaner, and more reliable result than anything old-school methods ever delivered. After meeting Capsoil’s founder and CTO, Raphael Ezra, Cytrynbaum realized the company had the potential to transform how cannabinoids, hemp derivatives, nutraceuticals, and even topicals are absorbed in the human body. The challenge begins with…

Read More

When Debra Dullaghan hit a wall with prescription medications and the emotional weight of a difficult life chapter, she turned to an unexpected remedy: CBD. What began as a personal experiment evolved into 55plus CBD, a brand dedicated to helping older adults navigate wellness with clarity, confidence, and a THC-free guarantee. In this conversation with Cannabis & Tech Today, Dullaghan shares how her own transformation sparked a mission to empower others, why education is key, and how co-founding the company with her son brought generational insight to every product and message. This interview has been edited for length and clarity.…

Read More

Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis. Here’s what you may have missed over the last week: Sunderstorm Acquires Lime to Expand House of Brands Into Pre-Rolls Sunderstorm announced the acquisition of California pre-roll brand Lime, marking a strategic expansion into one of cannabis’s largest and most competitive product categories. The move builds on the company’s established strength in edibles and vapes under the KANHA banner, extending its “house of brands” model into a format that continues to drive volume and…

Read More

If you’re considering a move toward eco-friendly packaging for your business, you’re joining a wave of companies that recognize sustainability as both an ethical choice and a smart one. Yet the transition isn’t always straightforward. Recent insights from industry leaders reveal that thoughtful preparation can make all the difference between a seamless shift and costly setbacks. Here are five key considerations to guide you, drawn from the latest research as of early 2026. 1. Understand the Real Financial Picture Sustainable materials often come with a higher upfront price tag, and that’s one of the biggest hurdles. Innovations like high-performing polyhydroxyalkanoates…

Read More

Jordan Isenstadt, Marino PR Jordan Isenstadt is a PR executive, strategist, and community builder with expertise at the intersection of cannabis, public policy, and emerging industries. With a background in political science and sociology and early professional experience in government and public affairs, Isenstadt has spent his career helping organizations navigate complex regulatory environments, cultural shifts, and high-stakes reputational moments. He is currently a Senior Vice President at Marino, where he built and leads the firm’s award-winning Cannabis, Psychedelics & Emerging Industries practice. Over the past decade, Isenstadt has advised cannabis operators, technology platforms, advocacy organizations, and institutions. His work…

Read More

With the global cannabis industry abuzz over what appears to be imminent rescheduling of cannabis in the United States to a less restrictive controlled substance, due to President Trump’s Executive Order, there are still several practicalities to implement. One of the issues in question is tracking patient data.  Last month, the President of the United States (POTUS) decreed to reschedule cannabis from its most restrictive category for controlled substances, Schedule I, to the less restrictive Schedule III, and tasked United States Attorney General Pam Bondi with making it happen.   Cannabis & Tech Today reached out to the United Nations’ International…

Read More